Is there a generic for Iodohippurate sodium i-123?

The FDA Orange Book does not currently list an approved generic (ANDA) for Iodohippurate sodium i-123. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Iodohippurate sodium i-123?

NEPHROFLOW (NDA 018289, GE HEALTHCARE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Iodohippurate sodium i-123 are approved?

Iodohippurate sodium i-123 is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Iodohippurate sodium i-123

Iodohippurate sodium i-123 is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:NEPHROFLOW · NDA 018289

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
NEPHROFLOW	GE HEALTHCARE	NDA 018289	—	Dec 28, 1984

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Iodohippurate sodium i-123 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo